🟠 #Intellia's rivals, including Verve Therapeutics (#VERV), Editas Medicine (#EDIT), and CRISPR Therapeutics (#CRSP), also saw notable stock declines on Friday. 
#CRISPR #biotech $VRTX $NTLA $PRME $EDIT @FDA